kavita patel. great to have you with us. first of all, i guess, here's the basic question. is it that there is such a discrepancy between what we pay here in the united states and what others pay abroad? >> yeah, simply put, we have too many people in between me, who prescribes the drug, and anybody who is actually picking it up at the counter. that comes in the forms of pharmacy benefiting managers, group purchasing organizations. you have very large, people call it the middlemen, you have seen some very prominent "new york times" articles exposing this. but there are a lot of people in between the drug manufacture, the prescriber, and the patient, and that's not lost, i think it shouldn't be lost on anyone. that's why you see such vast discrepancies. i can walk up and pay zero dollars copay. i don't understand all this talk about the cost of ozempic or mounjaro, and if you have an employer that's cut that out as a benefit, you can just simply take your insurance car and just get maybe some of the disopportunity cos, some of the rebates. there's patient assistance programs